Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

» IMCL's 10-Y Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with IMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )



Valuation & Return


Business Description

Industry: Biotechnology » Biotechnology
Compare: » details
» More Articles for IMCL


Articles On GuruFocus.com
No related article found.

More From Other Websites
IMMUNOCLIN CORP Financials Aug 01 2015
IMMUNOCLIN CORP Financials Jul 22 2015
Linking cancer drug prices to their performance May 27 2015
ImmunoClin Ltd. to Provide Contract Research Organization (CRO) Services for Crotoxin Phase I Part... May 20 2015
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom Apr 02 2015
Activist investor at Ariad Pharmaceuticals has long history of wins Mar 11 2015
ImmunoClin Corporation (IMCL) Relocates European Headquarters and Laboratories to London, UK Mar 10 2015
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Dec 22 2014
Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr.... Nov 06 2014
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Sep 29 2014
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with... Sep 29 2014
ImmunoClin Corporation (IMCL) Announces the Appointment of Infectious Disease Expert, Dr. Heinz... Aug 05 2014
IMMUNOCLIN CORP Files SEC form 8-K, Other Events Aug 01 2014
ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC Jul 29 2014
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Jul 24 2014
IMMUNOCLIN CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Jul 08 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)